0. Advocacy Webpage Graphics-Narrow -Standardize It 

There are many misconceptions about the disease of addiction, and a culture change is needed in this country to drive patients to the treatment options that have been proven to be effective at reducing overdose deaths and supporting patients in remission and recovery.

It is critical that our treatment infrastructure reflect this by facilitating the use of evidence-based, research-validated guidelines and standards for the treatment of addiction and employing competency-based addiction education for all healthcare providers.





The ASAM Criteria®, the most widely used and comprehensive set of guidelines for placement, continued stay and transfer/discharge of patients with addiction and co-occurring conditions, is a fundamental tool for the standardization of addiction medicine.



 
ASAM Level of Care Cert final
 




Featured Public Policy Statements

0. doctor patient

Regulation of Office-Based Opioid Treatment

OBOT promotes the treatment of addiction in the primary care setting, but ASAM understands that the use of controlled substances to treat addiction introduces the possibility of misuse and diversion of the very medications used for treatment.
2. medical-recordscrop

Prescription Drug Monitoring Programs (PDMPs)

Find out more about PDMPs and ASAM's recommendations on how they should be regulated.

Worldgen

Joint Public Correctional Policy Statement on the Treatment of Opioid Use Disorders for Justice Involved Individuals

Learn more about how ASAM and the American Correctional Association (ACA) are supporting the use of evidence-based practices for the treatment of opioid use disorders in correctional settings.





"By implementing a quality-driven national addiction treatment infrastructure, we can empower patients and their families with information on how to identify and access high-quality treatment."

-Dr. Kelly Clark, MD, MBA, DFASAM
Immediate-Past President of ASAM




Resources

dtd-webpage-title-banner

Appropriate Use of Drug Testing in Clinical Addiction Medicine

Provides guidance about the effective use of drug testing in the identification, diagnosis, treatment and promotion of recovery for patients with, or at risk for, addiction.

guideline-webpage-title-banner-1

The ASAM National Practice Guideline

The ASAM National Practice Guideline and associated resources provide information on evidence-based treatment of opioid use disorder.

confidentiality_472x176aa36159472bc604ca5b7ff000030b21a

Confidentiality (42 CFR Part 2)

Learn how ASAM continues to call for needed privacy protections as 42 CFR Part 2 regulations and the underlying statute are updated. 




Related News

newspapers-3488857_1920B
  • May 9, 2019

    ASAM Praises Funding for Critical SUD Workforce Programs in FY 2020 House Labor-HHS Appropriations Bill

    ASAM praised the House Appropriations Committee for including full funding for two new critical substance use disorder (SUD) workforce programs in its FY 2020 Labor, Health and Human Services (HHS), Education, and Related Agencies appropriations bill.
  • May 8, 2019

    ASAM Applauds Introduction of Comprehensive Addiction Resources Emergency (CARE) Act of 2019

    ASAM commended Senator Elizabeth Warren, Representatives Elijah Cummings, and all original co-sponsors for introducing the CARE Act of 2019. Modeled on successful, bipartisan legislation passed in 1990 to address the HIV/AIDS epidemic, the CARE Act would authorize $100 billion in federal funding over the next decade to states, local governments, and other organizations and institutions to support substance use disorder treatment programs, improve training for addiction treatment professionals in communities across the US, and expand access to treatments that meet national standards and are proven to save lives. 
  • May 8, 2019

    146 Members of the Coalition to Stop Opioid Overdose and Other Organizations Issue Letter of Support for the CARE Act of 2019

    ASAM joined 145 members of the Coalition to Stop Opioid Overdose and other organizations in sending a letter voicing support for the CARE Act of 2019. This legislation 2019 would provide $100 billion in federal funding over the next ten years to support federal research and programs to prevent drug use while expanding access to prevention, harm reduction, addiction treatment, mental health services, and recovery support services.